Abstract

Biotinylation in vivo is an extremely selective post-translational event where the enzyme biotin protein ligase (BPL) catalyzes the covalent attachment of biotin to one specific and conserved lysine residue of biotin-dependent enzymes. The biotin-accepting lysine, present in a conserved Met-Lys-Met motif, resides in a structured domain that functions as the BPL substrate. We have employed phage display coupled with a genetic selection to identify determinants of the biotin domain (yPC-104) of yeast pyruvate carboxylase 1 (residues 1075-1178) required for interaction with BPL. Mutants isolated using this strategy were analyzed by in vivo biotinylation assays performed at both 30 degrees C and 37 degrees C. The temperature-sensitive substrates were reasoned to have structural mutations, leading to compromised conformations at the higher temperature. This interpretation was supplemented by molecular modeling of yPC-104, since these mutants mapped to residues involved in defining the structure of the biotin domain. In contrast, substitution of the Met residue N-terminal to the target lysine with either Val or Thr produced mutations that were temperature-insensitive in the in vivo assay. Furthermore, these two mutant proteins and wild-type yPC-104 showed identical susceptibility to trypsin, consistent with these substitutions having no structural effect. Kinetic analysis of enzymatic biotinylation using purified Met --> Thr/Val mutant proteins with both yeast and Escherichia coli BPLs revealed that these substitutions had a strong effect upon K(m) values but not k(cat). The Met --> Thr mutant was a poor substrate for both BPLs, whereas the Met --> Val substitution was a poor substrate for bacterial BPL but had only a 2-fold lower affinity for yeast BPL than the wild-type peptide. Our data suggest that substitution of Thr or Val for the Met N-terminal of the biotinyl-Lys results in mutants specifically compromised in their interaction with BPL.

Highlights

  • § Current address: Hanson Centre for Cancer Research, Institute of Medical and Veterinary Science, Adelaide, South Australia 5000, Australia

  • We have previously shown that the 104 C-terminal residues of pyruvate carboxylase 1 from Saccharomyces cerevisiae can be expressed as a stable biotin domain in E. coli (7)

  • Analysis of whole cell lysates by antigIIIp antibody and avidin blots showed that fusion protein expression was inducible with IPTG and the polypeptide was biotinylated in vivo by the bacterial biotin protein ligase (BPL), BirA

Read more

Summary

EXPERIMENTAL PROCEDURES

Oligonucleotides were purchased from Geneworks Ltd (Adelaide, Australia). The restriction sites in the oligonucleotides are underlined, and mutagenic changes are in bold. The sequences of the oligonucleotides are as follows: YPC104B, 5Ј-CATACCATGGCAATGAGAAAAATTCGTGTTGCTG-3Ј; YPC3ЈB, 5Ј- TTACTGCAGACTATGCCTTAGTTTCAACAGGAACT-3Ј; Lys61Leu, 5Ј- AAGATGTGATCATTTCCATGAGCATGGCGCTTAATACGGCTA-3Ј; YPC104C, 5Ј-ACAGAATTCCATGGCAATGAGAAAAATTCGTGTTGCTG-3Ј; YPC-3ЈC, 5Ј-GCACAGCACCACCTGCAGACTA-3Ј

DNA Manipulations and Sequencing
Expression of gIIIp Fusion Proteins
Construction of Mutagenic Library
In Vitro Biotinylation of Mutant Biotin Domains on Phagemids
Analysis of Biotin Domain Mutants
Molecular Modeling
RESULTS
Ramachandran propertiesd Most favored Allowed Generous Disallowed
BirA Yeast BPL
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call